Policy & Regulation
Fosun Pharma chooses LifeSphere Safety MultiVigilance as global pharmacovigilance system
11 January 2019 -

China-based Fosun Pharma has chosen ArisGlobal's LifeSphere Safety MultiVigilance as its global pharmacovigilance system, it was reported yesterday.

Fosun will use ArisGlobal's technology to achieve full E2B (R3) compliance with greater efficiency and compliance. The selection was made in collaboration with ArisGlobal partner, Epharma Healthcare Technology Co Ltd, a one-stop solution provider for the pharmaceutical research and development industry.

A spokesperson for Fosun Pharma, said, 'Advanced technology, such as artificial intelligence and machine learning, are key LSMV capabilities that help us automate repetitive, manual tasks, thus improving efficiency and compliance. By switching to LifeSphere Safety MultiVigilance, our efforts to comply with regulations will be much more efficient.'

LifeSphere Safety MultiVigilance is presently utilised by more than 200 life sciences companies, including 9 health authorities.